MDNA Medicenna Therapeutics Corp.

0.1224USD0.1750 CAD · TSX-20.45%Mkt Cap: 11.30M USDP/E: —

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated…